We will give a presentation and a poster presentation at the 6^th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan via online from June 27 to June 29, 2021.

Details are given below.

June 27, 14:05-15:15 Poster session1 (1P-25)
Title：Evaluation of the extrapolation about the off-target effects of antisense oligonucleotides from in vitro to human
¹Integrated & Translational Science, Axcelead Drug Discovery Partners, Inc.
²Research and Development Division, Luxna Biotech Co., Ltd.
³Consulting, Axcelead Drug Discovery Partners, Inc.
*This presentation will be given by Axcelead Drug Discovery Partners, Inc.

June 28, 14:20-15:30 Poster session2(2P-23)
Title：The knockdown activity of GuNA-gapmer antisense oligonucleotides in heart
Luxna Biotech Co., Ltd.

June 28, 14:20-15:30 Poster session2(2P-30)
Title：Optimization for reducing hepatotoxicity by incorporating AmNA and SCP
Luxna Biotech Co., Ltd.

June 29, 16:00-16:15 Company symposium(C-3)
Title：Advances in antisense drug discovery that takes advantage of the characteristics of sugar-crosslinked artificial oligonucleotide 
Hideaki Sato, President & CEO, Luxna Biotech Co., Ltd. 

We are looking forward to joining us.
Please click here for details(Japanese only).